» Articles » PMID: 27018801

Solid-state NMR Structure of a Pathogenic Fibril of Full-length Human α-synuclein

Abstract

Misfolded α-synuclein amyloid fibrils are the principal components of Lewy bodies and neurites, hallmarks of Parkinson's disease (PD). We present a high-resolution structure of an α-synuclein fibril, in a form that induces robust pathology in primary neuronal culture, determined by solid-state NMR spectroscopy and validated by EM and X-ray fiber diffraction. Over 200 unique long-range distance restraints define a consensus structure with common amyloid features including parallel, in-register β-sheets and hydrophobic-core residues, and with substantial complexity arising from diverse structural features including an intermolecular salt bridge, a glutamine ladder, close backbone interactions involving small residues, and several steric zippers stabilizing a new orthogonal Greek-key topology. These characteristics contribute to the robust propagation of this fibril form, as supported by the structural similarity of early-onset-PD mutants. The structure provides a framework for understanding the interactions of α-synuclein with other proteins and small molecules, to aid in PD diagnosis and treatment.

Citing Articles

High-resolution Cryo-EM Structure Determination of a-Synuclein-A Prototypical Amyloid Fibril.

Sanchez J, Pierson J, Borcik C, Rienstra C, Wright E Bio Protoc. 2025; 15(3):e5171.

PMID: 39959285 PMC: 11825309. DOI: 10.21769/BioProtoc.5171.


Investigation of All Disease-Relevant Lysine Acetylation Sites in α-Synuclein Enabled by Non-canonical Amino Acid Mutagenesis.

Shimogawa M, Li M, Park G, Ramirez J, Lee H, Watson P bioRxiv. 2025; .

PMID: 39896484 PMC: 11785115. DOI: 10.1101/2025.01.21.634178.


Molecular Insights into α-Synuclein Fibrillation: A Raman Spectroscopy and Machine Learning Approach.

Coles N, Elsheikh S, Quesnel A, Butler L, Jennings C, Tarzi C ACS Chem Neurosci. 2025; 16(4):687-698.

PMID: 39875340 PMC: 11843597. DOI: 10.1021/acschemneuro.4c00726.


OPTO: Automated Optimization for Solid-State NMR Spectroscopy.

Borcik C, DeZonia B, Ravula T, Harding B, Garg R, Rienstra C J Am Chem Soc. 2025; 147(4):3293-3303.

PMID: 39814553 PMC: 11808819. DOI: 10.1021/jacs.4c13295.


Strategies of positron emission tomography (PET) tracer development for imaging of tau and α-synuclein in neurodegenerative disorders.

Mekala S, Wu Y, Li Y RSC Med Chem. 2024; .

PMID: 39678127 PMC: 11638850. DOI: 10.1039/d4md00576g.


References
1.
Grishaev A, Bax A . An empirical backbone-backbone hydrogen-bonding potential in proteins and its applications to NMR structure refinement and validation. J Am Chem Soc. 2004; 126(23):7281-92. DOI: 10.1021/ja0319994. View

2.
Delaglio F, Grzesiek S, Vuister G, Zhu G, Pfeifer J, Bax A . NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995; 6(3):277-93. DOI: 10.1007/BF00197809. View

3.
Bousset L, Pieri L, Ruiz-Arlandis G, Gath J, Jensen P, Habenstein B . Structural and functional characterization of two alpha-synuclein strains. Nat Commun. 2013; 4:2575. PMC: 3826637. DOI: 10.1038/ncomms3575. View

4.
Luk K, Song C, OBrien P, Stieber A, Branch J, Brunden K . Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A. 2009; 106(47):20051-6. PMC: 2785290. DOI: 10.1073/pnas.0908005106. View

5.
Appel-Cresswell S, Vilarino-Guell C, Encarnacion M, Sherman H, Yu I, Shah B . Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease. Mov Disord. 2013; 28(6):811-3. DOI: 10.1002/mds.25421. View